Cargando…

Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017‐2021: Results From the Canadian Early Arthritis Cohort

OBJECTIVE: Adults with rheumatoid arthritis (RA) are at a higher risk for infections, including influenza and related complications. We identified influenza vaccination coverage in adults newly diagnosed with RA and examined sociodemographic RA characteristics and attitudes associated with vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ta, Viviane, Schieir, Orit, Valois, Marie‐France, Colmegna, Ines, Hitchon, Carol, Bessette, Louis, Hazlewood, Glen, Thorne, Carter, Pope, Janet, Boire, Gilles, Tin, Diane, Keystone, Edward C., Bykerk, Vivian P., Bartlett, Susan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274339/ https://www.ncbi.nlm.nih.gov/pubmed/35349768 http://dx.doi.org/10.1002/acr2.11427

Ejemplares similares

Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort
por: Kudaeva, Fatima, et al.
Publicado: (2019)

A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort
por: Andersen, Kathleen M., et al.
Publicado: (2021)

A quarter of patients time their early rheumatoid arthritis onset differently than physicians
por: Ellingwood, Leah, et al.
Publicado: (2019)

Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort
por: Ellingwood, L., et al.
Publicado: (2019)

Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis
por: Kuriya, B., et al.
Publicado: (2019)

High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years
por: Barber, Claire E. H., et al.
Publicado: (2018)

Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis
por: Pokharel, Gyanendra, et al.
Publicado: (2019)

Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)
por: Lee, Jason J., et al.
Publicado: (2016)

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)
por: Barnabe, Cheryl, et al.
Publicado: (2015)

The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort§
por: Boyd, Tristan A, et al.
Publicado: (2013)

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
por: Bykerk, Vivian P, et al.
Publicado: (2016)

Multiparameter Phospho-Flow Analysis of Lymphocytes in Early Rheumatoid Arthritis: Implications for Diagnosis and Monitoring Drug Therapy
por: Galligan, Carole L., et al.
Publicado: (2009)

Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis
por: Keystone, Edward C., et al.
Publicado: (2016)

The rapid kinetics of optimal treatment with subcutaneous methotrexate in early inflammatory arthritis: an observational study
por: O’Connor, Anna, et al.
Publicado: (2016)

The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis
por: Pope, Janet E, et al.
Publicado: (2014)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Development of a self-administered early inflammatory arthritis detection tool
por: Bell, Mary J, et al.
Publicado: (2010)

Management of Inflammatory Arthritis in pregnancy: a National Cross-Sectional Survey of Canadian rheumatologists
por: De Vera, Mary A., et al.
Publicado: (2019)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
por: Umaefulam, Valerie, et al.
Publicado: (2021)

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
por: Barber, Claire E.H., et al.
Publicado: (2019)

Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study
por: Hazlewood, Glen S, et al.
Publicado: (2020)

Development of an interdisciplinary early rheumatoid arthritis care pathway
por: Gukova, Xenia, et al.
Publicado: (2022)

Identification of Distinct Disease Activity Trajectories in Methotrexate‐Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty‐Four Months
por: Bykerk, Vivian P., et al.
Publicado: (2021)

Oxidation in rheumatoid arthritis
por: Hitchon, Carol A, et al.
Publicado: (2004)

The Synovium in Rheumatoid Arthritis
por: Hitchon, Carol A, et al.
Publicado: (2011)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Rheumatoid arthritis prevalence in Quebec
por: Bernatsky, Sasha, et al.
Publicado: (2014)

“Walking into the unknown…” key challenges of pregnancy and early parenting with inflammatory arthritis: a systematic review and thematic synthesis of qualitative studies
por: Rebić, Nevena, et al.
Publicado: (2021)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)
por: Pope, Janet E, et al.
Publicado: (2018)

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis
por: Hitchon, Carol A, et al.
Publicado: (2019)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

Effect of Training on Patient Self‐Assessment of Joint Counts in Rheumatoid Arthritis: A Systematic Review
por: Tam, Keith, et al.
Publicado: (2021)

Prevalence and Incidence of Rheumatoid Arthritis in Canadian First Nations and Non–First Nations People: A Population-Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab
por: Choy, Ernest, et al.
Publicado: (2022)

The Impact of Arthritis on Canadian Women
por: Badley, Elizabeth M, et al.
Publicado: (2004)

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis
por: de França, Natalia Regine, et al.
Publicado: (2022)

Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register
por: Symmons, Deborah PM, et al.
Publicado: (2006)

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study
por: Moura, Cristiano S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_de131r3ekh78eqsqlh251mu0pe